Cargando…

How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review

Hepatitis B virus (HBV) infection is a major global public health challenge associated with significant morbidity and mortality. Due to worldwide population aging, HBV infection in the elderly will become increasingly prevalent. Effective universal vaccination programs exist but these are largely ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Chan Keat, Brennan, Paul N, Dillon, John F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748119/ https://www.ncbi.nlm.nih.gov/pubmed/36532948 http://dx.doi.org/10.2147/CIA.S366255

Ejemplares similares

Virological Treatment Monitoring for Chronic Hepatitis B
por: Loggi, Elisabetta, et al.
Publicado: (2022)

How to compare antivirals in the treatment of chronic hepatitis B?
por: Ozaras, Resat, et al.
Publicado: (2009)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions
por: Ahn, Sang Hoon, et al.
Publicado: (2010)

Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
por: Xu, Xu, et al.
Publicado: (2023)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)

Histologic Study of Chronic Active Hepatitis C; Comparison with Chronic Active Hepatitis B
por: Hahm, Ki Baik, et al.
Publicado: (1992)

Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up
por: Lim, Chong Teik, et al.
Publicado: (2020)

Chronic hepatitis B patients: A relation of age and comorbidities
por: Vyas, Ashish K., et al.
Publicado: (2019)

Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world
por: Donaldson, Sarah R., et al.
Publicado: (2022)

How Can We Make Decision for Patients With Chronic Hepatitis B According to Hepatitis B Virus (HBV) DNA Level?
por: Keshvari, Maryam, et al.
Publicado: (2014)

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?
por: Loglio, Alessandro, et al.
Publicado: (2020)

Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review
por: Brennan, Paul, et al.
Publicado: (2020)

Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
por: Wu, Cheng, et al.
Publicado: (2015)

Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B
por: Hui, Alex Y., et al.
Publicado: (2003)

Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
por: Pham, Thi T. Hang, et al.
Publicado: (2023)

How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
por: Lee, Hye Won, et al.
Publicado: (2020)

Cost-Effective Pharmacologic Therapies to Treat Chronic Hepatitis B: How Far Have We Really Come?
por: Holbrook, Michelle
Publicado: (2008)

Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
por: Clare, Kathleen, et al.
Publicado: (2022)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
por: Lok, Anna S., et al.
Publicado: (2019)

Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials
por: Tran, Tram T., et al.
Publicado: (2015)

Impact of Stigma on People Living with Chronic Hepatitis B
por: Smith-Palmer, Jayne, et al.
Publicado: (2020)

Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA
por: Gao, Wen-Kang, et al.
Publicado: (2022)

Unresolved issues of immune tolerance in chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2020)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
por: Liu, Yayun, et al.
Publicado: (2019)

Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis
por: Brennan, Paul N, et al.
Publicado: (2022)

Effects of reduced glutathione therapy on chronic hepatitis B
por: Qian, Li, et al.
Publicado: (2017)

The Search for Cost-Effective Treatment of Chronic Hepatitis B
por: Smith, Vanessa E., et al.
Publicado: (2008)

Patient Preferences and Their Influence on Chronic Hepatitis B-A Review
por: Zhang, Lin, et al.
Publicado: (2023)

Characterization of antiphospholipid antibodies in chronic hepatitis B infection
por: Huh, Ji Young, et al.
Publicado: (2011)

Correction to: Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
por: Liu, Yayun, et al.
Publicado: (2019)

Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA
por: Liu, Ya-Yun, et al.
Publicado: (2018)

Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis
por: Ye, Junzhao, et al.
Publicado: (2021)

Combination Therapy for Chronic Hepatitis B: Current Indications
por: Paul, Navin, et al.
Publicado: (2011)

Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature‐Mutation in Treated Chronic Hepatitis B Patients
por: Huang, Qi, et al.
Publicado: (2020)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
por: Lim, Young‐Suk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uk2ea364jjoln09iok8imav5be